@xconomy.com 3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com 4 years ago
Review: Inside the House of Lies at Theranos
@xconomy.com 5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation
@xconomy.com 5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More